Citations
52 citation(s) found for "Jain, Tania".
Phase II trial of nab‐paclitaxel in patients with relapsed or refractory multiple myeloma
Jain, Tania , Dueck, Amylou C. , Ginos, Brenda, Mayo, Angela, Reeder, Craig B. , Chesi, Marta , Stewart, A. Keith, Bergsagel, P. Leif , Bergsagel, P. Leif , Ginos, Brenda F, Mıkhael, Joseph , Dueck, A. C. , Kosiorek, Heidi , Fonseca, Rafaël , Jain, Tania
American Journal of Hematology | September 1, 2016 | Volume: 91 | Issue: 12 | Pages: No page available
Bone Disease in Myeloma: The Claws of CRAB
Jain, Tania , Fonseca, Rafaël , Jain, Tania
Clinical Cancer Research | January 21, 2016 | Volume: 22 | Issue: 6 | Pages: 1301-1303
10.1158/1078-0432.ccr-15-2981
| PMID 26792259
Abstract A dynamic approach to use bisphosphonates according to biomarkers of bone metabolism is presented in the Z-MARK study by Raje and colleagues. This is a major step forward toward a rational approach to bisphosphonate usage. Clin Cancer Res; 22(6); 1301–3. ©2016 AACR. See related article by Raje et al., p. 1378